We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.52B
AUM Growth
+$17.4M
Cap. Flow
-$662K
Cap. Flow %
-0.04%
Top 10 Hldgs %
28.34%
Holding
229
New
9
Increased
55
Reduced
125
Closed
23

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$30.2M
2
GSK icon
GSK
GSK
+$17.8M
3
SCHW
Charles Schwab
SCHW
+$13.7M
4
BTI icon
British American Tobacco
BTI
+$8.81M
5
CMCSA icon
Comcast
CMCSA
+$5.97M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$18.9M
2
SJM icon
J.M. Smucker
SJM
+$17.7M
3
PNC icon
PNC Financial Services
PNC
+$14.4M
4
FITB
Fifth Third Bancorp
FITB
+$11.9M
5
CMA
Comerica
CMA
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Consumer Staples 12.53%
3 Technology 9.64%
4 Financials 9.02%
5 Energy 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THG icon
226
Hanover Insurance
THG
$7.78B
-1,756
Closed -$226K
WAFD icon
227
WaFd
WAFD
$2.81B
-9,485
Closed -$286K
WMG icon
228
Warner Music
WMG
$13.2B
-7,016
Closed -$234K
HTLF
229
DELISTED
Heartland Financial USA, Inc.
HTLF
-5,614
Closed -$215K

Similar funds

GW Henssler & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, GW Henssler & Associates held 229 positions worth $1.52B, up 1.2% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GW Henssler & Associates's Q2 2023 filing shows 9 new, 55 increased, 125 reduced and 23 closed positions. Its largest new stake was Dollar General: 152,491 shares worth $25.9M. The largest sale was Novartis, an estimated $18.9M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Staples and Technology.

  • GW Henssler & Associates's largest Q2 2023 buy was Dollar General: 152,491 shares worth $25.9M.
  • GW Henssler & Associates added most to GSK in Q2 2023, an estimated $17.8M increase.
  • GW Henssler & Associates's biggest Q2 2023 reduction was Novartis, cutting an estimated $18.9M.
  • GW Henssler & Associates fully exited J.M. Smucker in Q2 2023, selling an estimated $17.7M.
  • GW Henssler & Associates's ten largest holdings make up 28% of its $1.52B portfolio in Q2 2023.
  • GW Henssler & Associates opened 9 new positions and closed 23 in Q2 2023.
  • GW Henssler & Associates's portfolio value rose 1.2% quarter-over-quarter to $1.52B.

Based on GW Henssler & Associates's 13F filing for Q2 2023, filed 2 Aug 2023.